Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OmniCorder Technologies, Inc. (OMCT) -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (11)	1/20/2004 8:12:59 PM
From: RikRichter	Respond to of 63

The only answer I have for you now is the price data on PMOS. The reverse merger occurred on December 19, 2003 so you could see the price spike since then. finance.yahoo.com If you listened to the conference call, you would have heard the CEO's case that PMOS has a revolutionary new medical diagnostics tool which is patented and FDA-approved. You should try directing your questions to management to see if they will respond.

To: rrufff who wrote (11)	3/21/2004 10:32:53 AM
From: Mahatmabenfoo	Read Replies (1) \| Respond to of 63

Ruff asked: "What do you have for revenue projections over the next 24 months". ZERO. I based that on the fact this company got FDA approval for its device in December 1999. A few months after that, the CEO predicted "Over the next year.... his 25-employee company will quadruple as hospitals and doctors catch on to the device" businessweek.com The reality: NO SALES IN 4 years! And instead of doubling, the number of employees DECLINED from 25 to only 11. That's what's behind this hot prospect: 11 EMPLOYEES! This is HYPE. The company makes noise about how its product is "available"; but very quiet about the fact of no sales for 4 years -- or ever. Hard to call this a "hot prospect"! - Charles